Eculizumab treatment of thrombotic microangiopathy in a patient with ulcerative colitis

Volume: 13, Issue: 3, Pages: 344 - 348
Published: Oct 14, 2019
Abstract
Secondary thrombotic microangiopathy (TMA) can be induced by several underlying conditions and drugs, yet coexistence of TMA and inflammatory bowel disease (IBD) has only infrequently been documented. A successful management beyond supportive care in cases with secondary TMA represents a challenge, as some underlying conditions might amplify complement dysregulation or even unmask a genetic predisposition to atypical hemolytic uremic syndrome...
Paper Details
Title
Eculizumab treatment of thrombotic microangiopathy in a patient with ulcerative colitis
Published Date
Oct 14, 2019
Volume
13
Issue
3
Pages
344 - 348
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.